Journal menu

open access
Journal of Cancer Chemotherapy

+44 7897 072181

Editorial Board

The Editorial Board of the journal is responsible for maintaining the quality and integrity of the journal's content. The board members are experts in their respective fields and play a crucial role in the peer review process, ensuring that all articles published meet the highest academic standards.

The Editorial Board is committed to upholding the principles of academic excellence, transparency, and ethical publishing practices. They work closely with authors, reviewers, and the editorial team to facilitate a smooth publication process.

Editor-in-Chief

Mohanad Diab

Mohanad Diab MBBS, MD [Profile Link]

Editor-in-Chief

Department: Department of Oncology

Affiliation: Oncology, Karolinska University, Stockholm

Designation: Director of Oncology Hematology Services

Country: Sweden

I worked as a consultant medical Oncologist since 2008 in the West Gotland Region in Sweden which has two main Oncology departments (I was the Key person in Establishing and leading the oncology clinic team in the second Oncology Clinic) those two hospitals are far of each others about 60 km and serve about 160 thousand inhabitant with a capacity of 525 beds for the first hospital and 300 bed for the second hospital.

The Oncology departments consist of ambulatory section (cancer patients with acute cases). Chemotherapy section (patients who under ongoing chemotherapy treatment) and out patients’ clinic. (Curative and Palliative patients). I lead and organize the Oncology department at the second hospital (skene Hospital).

I had my own Oncology studies as a primary investigator and I participate in many studies at our Oncology department for different Tumor diagnosis

Primary investigator in LETET , RALF, PARIS, RADIUM, PICASOS, ELITE Studies.

Currently I am a primary investigator in several international, regional and local studies.

Since may 2014 working as a Consultant medical Oncologist at NMC specialty hospital in Abu Dhabi, I built up the Oncology clinic at NMC hospital from Zero where, all chemotherapy protocols according to highest international standards. Number of my patients in there increased in a very fast way and the one room clinic turned to a full floor in 2 years.

I also established the oncology clinic at royal nmc hospital.

Since I joined NMC I built up a full team for tumor board consist of Onc-surgeon, Onco-radiologist and onco-pathologist and created a tumor board team. I have made those teams in all nmc hospitals.

In 2017 I became the Chair of Oncology line in NMC group until January 2022.

February 2022 Director of Oncology of Abu Dhabi Burjeel and head of Oncology department of Burjeel hospital until October 2024.

Director of Oncology/Hematology Services at Mediclinic Hospital.

Participated in more than 100 publications related to Oncology and Haematology. Details available upon request.

Editorial Members

Diamantopoulos

Diamantopoulos MD

Editorial Member

Affiliation: School of Medicine, Aristotle University of Thessaloniki

Department: Department of Urology

Designation: Consultant Urologist Clinical Instructor

Country: Greek

Dr. Christos Diamantopoulos is a Consultant Urologist at the General Hospital of Katerini, Greece. He completed his medical degree at the Democritus University of Thrace, followed by a Master of Science (MSc) in Human Reproduction. He trained extensively in Urology at the General Hospital of Thessaloniki "Papageorgiou" and received the Urology Specialty Title in 2025. He has pursued advanced training in uro-oncology, minimally invasive surgery, and reproductive medicine, and actively contributes as a reviewer in international journals.

Meng-Yao Li

Meng-Yao Li Ph.D [Profile Link]

Editorial Member

Affiliation: Shanghai Jiao Tong University School of Medicine, Shanghai

Department: Department of Oncology

Designation: Assistant Professor

Country: China

Dr. Meng-Yao Li is currently serving as an assistant professor at Renji Hospital Affiliated to Shanghai Tong University School of Medicine. He obtained his graduate degree from the prestigious Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, under the esteemed guidance of Prof. Guo-Qiang Lin. Li has made significant contributions to various scientific publications in renowned journals such as Aggregate, Sci. China Chem., Angew. Chem. Int. Ed., Nat. Commun., Green Chem., iScience, Org. Lett., and Chem. Commun. His research output comprises more than 30 SCI papers that have garnered a total citation count of 500, resulting in a personal H-index value of 13. His research interests are investigating green synthesis, solvent-free and catalyst-free reaction; exploring drug design, synthesis, and their antitumor properties; developing and utilizing patient-derived organoid models as well as patient-derived tumor xenografts; studying drug resistance mechanisms in biliary and pancreatic tumors.

Kunal Goyal

Kunal Goyal MBBS MD DM Clinical hematology [Profile Link]

Editorial Member

Affiliation: Kokilaben hospital Mumbai ICTC Mumbai

Department: Department of Clinical Hematology, Bone marrow transplant and cellular therapies CAR-T

Designation: HOD dept of Hemato-Oncology

Country: India

"I am Dr. Kunal Goyal, a Hematologist with a deep passion for advancing the treatment of blood cancers. I specialize in Bone Marrow Transplantation (BMT) and cutting-edge Cellular Therapies, particularly Chimeric Antigen Receptor T-cell (CAR-T) therapies.

My journey in hematology began with a strong academic foundation. I earned my MBBS with Gold Medal honors, followed by an MD (Silver Medallist) and a DM in Clinical Hematology. I had the privilege of training at Tata Memorial Centre (ACTREC), Mumbai, where I honed my skills in BMT and CAR-T therapies as a Specialist senior Resident.

I am dedicated to providing the highest quality care to my patients.

I am proud to have played a key role in establishing and leading the Bone Marrow Transplant and CAR-T Therapy program at Kokilaben Dhirubhai Ambani Hospital, Navi Mumbai and BMT unit at HBCH (TATA- Varanasi in 2022)

I also run a leading cancer day care chain ICTC Mumbai (Mumbai based) to maintaining highest standard of treatment while keeping treatment affordable for the needy patients.

I am an active member of leading professional organizations such as ISHBT, ISBMT, ASCO, and ASH (trainee), staying abreast of the latest advancements in the field.

I believe in a patient-centered approach to care, emphasizing personalized treatment plans and providing comprehensive support throughout the treatment journey.